Ranked by shared topics, with one result from each original episode.
“From the chemistry of synthetic vanillin to the regulatory loopholes behind GRAS labeling, we explore how these additives can influence health—not just through potential toxicity, but by activating the brain's reward system in ways that may affect behavior.”
“Air pollution leaves a biological fingerprint on our lungs, our blood vessels, and even our brains, eroding the body's defenses, triggering inflammation, weakening the blood-brain barrier, and accelerating cognitive decline.”
“In this Aliquot, along with Dr. Eran Elinav, I explore how gluten affects the gut barrier, who actually needs to avoid it, and the practical strategies that can help you build a more resilient gut.”
“In this Aliquot, I'm joined by exercise-oncology researcher Dr. Kerry Courneya to identify and prioritize the lifestyle behaviors that account for much of the difference in cancer risk and have the greatest long-term impact.”
“In this Aliquot, I'm joined by Drs. Martin Gibala, Luc van Loon, and Brad Schoenfeld to break down how to manage load, train in joint-friendly ways, reduce inflammation, and separate supplements supported by evidence from those that remain uncertain.”
“These changes increase infection risk, weaken vaccine responses, and reduce early cancer surveillance. Yet immune aging is not fixed. Movement, sleep, stress regulation, temperature exposure, and nutrition shape immune cell balance and inflammatory activity over time.”
“In this Aliquot, I explain why visceral fat behaves so differently from other fat, how it drives insulin resistance and chronic disease, and what research shows about the most effective ways to reduce it.”
“Because some long-chain PFAS travel through a similar pathway, researchers are now asking whether beta-glucans might also help the body eliminate these persistent "forever chemicals."”
“Recent discoveries in the field of epigenetics suggest we might be able to slow aging, based on the realization that not everyone ages at the same rate. Evidence suggests that drugs or other medical procedures can slow epigenetic aging, but other factors, such as diet and disease states influence it too.”
“Statins can reduce the risk of heart disease by 30 to 40 percent due to their ability to increase LDL receptor activity and reduce blood cholesterol levels. Whether the drugs are overprescribed (or perhaps under-prescribed) is a matter of great debate.”